<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011675'>Arrhythmias</z:hpo> play a significant role in the mortality and morbidity as well as hospitalizations of patients who carry a diagnosis of <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>With improving survival in a world of novel medications and devices, an understanding of the pathophysiology and management of these <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> is crucial </plain></SENT>
<SENT sid="2" pm="."><plain>Majority of the basic <z:hpo ids='HP_0001635'>heart failure</z:hpo> medications such as beta- -blockers, <z:chebi fb="0" ids="35457">angiotensin converting enzyme inhibitors</z:chebi>/<z:chebi fb="0" ids="27584,30834">aldosterone</z:chebi> receptor blockers and <z:chebi fb="0" ids="27584,30834">aldosterone</z:chebi> <z:chebi fb="68" ids="48706">antagonists</z:chebi> play a pivotal role in prevention of <z:hpo ids='HP_0001645'>sudden cardiac deaths</z:hpo> which can be a direct/indirect result of these <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Anti-arrhythmic drugs and implantable cardioverter-defibrillators were also beneficial in selected patients </plain></SENT>
<SENT sid="4" pm="."><plain>Innovative electrophysiological techniques need to be considered in special situations </plain></SENT>
</text></document>